Hourglass Capital LLC Sells 1,205 Shares of HCA Healthcare, Inc. $HCA

Key Points

• Hourglass Capital LLC decreased its holdings in HCA Healthcare by 5.7% in Q2 2023, selling 1,205 shares, which now represent about 1.9% of its total portfolio.
• Multiple large investors have recently acquired new stakes in HCA Healthcare, with institutional ownership standing at 62.73%.
• HCA Healthcare's stock currently has a consensus rating of "Moderate Buy" with an average target price of $431.07, following various positive changes in analyst ratings.

Hourglass Capital LLC lowered its holdings in HCA Healthcare, Inc. (NYSE:HCA - Free Report) by 5.7% in the second quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The firm owned 19,990 shares of the company's stock after selling 1,205 shares during the period. HCA Healthcare makes up about 1.9% of Hourglass Capital LLC's portfolio, making the stock its 14th largest holding. Hourglass Capital LLC's holdings in HCA Healthcare were worth $7,658,000 as of its most recent SEC filing.

Several other large investors also recently modified their holdings of HCA. Cheviot Value Management LLC acquired a new stake in shares of HCA Healthcare during the 1st quarter worth $26,000. Saudi Central Bank acquired a new stake in shares of HCA Healthcare during the 1st quarter worth $26,000. WPG Advisers LLC acquired a new stake in HCA Healthcare in the first quarter valued at about $27,000. Ameriflex Group Inc. acquired a new stake in HCA Healthcare in the second quarter valued at about $27,000. Finally, Chung Wu Investment Group LLC acquired a new stake in HCA Healthcare in the second quarter valued at about $27,000. 62.73% of the stock is owned by institutional investors and hedge funds.

Analyst Ratings Changes

A number of brokerages have recently commented on HCA. Truist Financial set a $460.00 price target on HCA Healthcare in a research note on Tuesday. Wells Fargo & Company lifted their price target on HCA Healthcare from $375.00 to $412.00 and gave the company an "equal weight" rating in a research note on Tuesday, October 7th. Wall Street Zen raised HCA Healthcare from a "hold" rating to a "buy" rating in a research note on Saturday, July 5th. Bank of America lifted their price objective on HCA Healthcare from $375.00 to $410.00 and gave the stock a "neutral" rating in a research note on Wednesday, September 10th. Finally, JPMorgan Chase & Co. lifted their price objective on HCA Healthcare from $360.00 to $370.00 and gave the stock a "neutral" rating in a research note on Monday, August 4th. One analyst has rated the stock with a Strong Buy rating, ten have given a Buy rating and nine have given a Hold rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average target price of $431.07.

HCA Healthcare Stock Up 0.5%

NYSE HCA opened at $420.38 on Thursday. The company has a market cap of $98.37 billion, a price-to-earnings ratio of 17.67, a P/E/G ratio of 1.32 and a beta of 1.40. HCA Healthcare, Inc. has a 52 week low of $289.98 and a 52 week high of $439.01. The business has a 50 day moving average price of $408.25 and a 200-day moving average price of $377.15.

HCA Healthcare (NYSE:HCA - Get Free Report) last released its quarterly earnings data on Friday, July 25th. The company reported $6.84 EPS for the quarter, beating the consensus estimate of $6.20 by $0.64. HCA Healthcare had a negative return on equity of 7,363.11% and a net margin of 8.21%.The firm had revenue of $18.61 billion during the quarter, compared to the consensus estimate of $18.49 billion. During the same quarter in the previous year, the company posted $5.50 earnings per share. The company's quarterly revenue was up 6.4% on a year-over-year basis. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. On average, equities research analysts anticipate that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Announces Dividend

The company also recently declared a quarterly dividend, which was paid on Tuesday, September 30th. Stockholders of record on Tuesday, September 16th were paid a dividend of $0.72 per share. The ex-dividend date was Tuesday, September 16th. This represents a $2.88 annualized dividend and a dividend yield of 0.7%. HCA Healthcare's dividend payout ratio is presently 12.11%.

Insider Buying and Selling at HCA Healthcare

In related news, EVP Michael S. Cuffe sold 3,836 shares of the stock in a transaction dated Monday, September 8th. The stock was sold at an average price of $418.84, for a total transaction of $1,606,670.24. Following the sale, the executive vice president owned 31,503 shares of the company's stock, valued at approximately $13,194,716.52. This represents a 10.85% decrease in their position. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Insiders own 1.30% of the company's stock.

About HCA Healthcare

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.

Want to see what other hedge funds are holding HCA? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for HCA Healthcare, Inc. (NYSE:HCA - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.